External counterpulsation

From Wikipedia, the free encyclopedia
  (Redirected from EECP)
Jump to: navigation, search
Illustration depicting Cardiac External Counterpulsation

External counterpulsation therapy (ECP) is a procedure performed on individuals with angina or heart failure or cardiomyopathy in order to diminish symptoms of ischemia, improve functional capacity and quality of life. In various studies, ECP has been shown to relieve angina,[1][2] and decrease the degree of ischemia in a cardiac stress test.[2][3]


While an individual is undergoing ECP, he/she has pneumatic cuffs on his or her legs and is connected to telemetry monitors that monitor heart rate and rhythm. The most common type in use involves three cuffs placed on each leg (on the calves, the lower thighs, and the upper thighs (or buttock)). The cuffs are timed to inflate and deflate based on the individual's electrocardiogram. The cuffs should ideally inflate at the beginning of diastole and deflate at the beginning of systole. During the inflation portion of the cycle, the calf cuffs inflate first, then the lower thigh cuffs and finally the upper thigh cuffs. Inflation is controlled by a pressure monitor, and the cuffs are inflated to about 200 mmHg.

When timed correctly, this will decrease the afterload that the heart has to pump against, and increase the preload that fills the heart, increasing the cardiac output.[4] In this way, ECP is similar to the intra-aortic balloon pump (IABP). Since it increases pressure in the aorta while the heart is relaxing (during diastole) ECP also increases blood flow into the coronary arteries, which also occurs during that phase.

Physiological considerations[edit]

One theory is that ECP exposes the coronary circulation to increased shear stress, and that this results in the production of a cascade of growth factors that result in angiogenesis.[5] ECP is a rehabilitation process that provides mechanical external cardiac assistance on a consistent regimen resulting in significant improvement in energy and exercise tolerance much like an exercise program. By restoring oxygenated blood flow, there are abundant benefits to the body. This restoration of nutrient rich blood flow revives tissue in parts of the heart and body that have become 'stunned' or 'hibernated' due to restricted or blocked blood flow.[citation needed] The heart benefits greatly as patients will see an improvement in structure, strength (contracility) and a reduction in afterload (workload) due to the reduction in systemic vascular resistance.[citation needed] Patients will see improvements in symptoms of chest pain, shortness of breath, chronic fatigue (tiredness) as well as a significant improvement in exercise tolerance (energy).[citation needed]

Indications and Contraindications[edit]



See also[edit]


  1. ^ Zheng ZS, Li TM, Kambic H, et al. (1983). "Sequential external counterpulsation (SECP) in China". Trans Am Soc Artif Intern Organs. 29: 599–603. PMID 6673295. 
  2. ^ a b Arora RR, Chou TM, Jain D, et al. (June 1999). "The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of ECP on exercise-induced myocardial ischemia and anginal episodes". J. Am. Coll. Cardiol. 33 (7): 1833–40. doi:10.1016/S0735-1097(99)00140-0. PMID 10362181. 
  3. ^ Lawson WE, Hui JC, Zheng ZS, et al. (1996). "Improved exercise tolerance following enhanced external counterpulsation: cardiac or peripheral effect?". Cardiology. 87 (4): 271–5. doi:10.1159/000177103. PMID 8793157. 
  4. ^ Werner D, Schneider M, Weise M, Nonnast-Daniel B, Daniel WG (October 1999). "Pneumatic external counterpulsation: a new noninvasive method to improve organ perfusion". Am. J. Cardiol. 84 (8): 950–2, A7–8. doi:10.1016/S0002-9149(99)00477-4. PMID 10532522. 
  5. ^ Soran O, Crawford LE, Schneider VM, Feldman AM (March 1999). "Enhanced external counterpulsation in the management of patients with cardiovascular disease". Clin Cardiol. 22 (3): 173–8. doi:10.1002/clc.4960220304. PMID 10084058. 
    Manchanda A, Soran O (October 2007). "Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure". J. Am. Coll. Cardiol. 50 (16): 1523–31. doi:10.1016/j.jacc.2007.07.024. PMID 17936150.